ALLEGRA MEDICAL TECHNOLOGIES LIMITED - Announcements

0.00%

2.9¢

Currently unlisted.

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a... Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

AMT	Long Term Suspended Entities	PRICE SENSITIVE	18/10/24	195.7KB	Share
AMT	Supplementary Bidder's Statement	PRICE SENSITIVE	09/10/24	116.43KB	Share
AMT	Variation of Takeover Bid	PRICE SENSITIVE	30/09/24	155.55KB	Share
AMT	Variation of Takeover Bid	PRICE SENSITIVE	16/09/24	164.03KB	Share
AMT	Variation of Takeover Bid	PRICE SENSITIVE	02/09/24	149.37KB	Share
AMT	Variation of Takeover Bid	PRICE SENSITIVE	16/08/24	148.6KB	Share
AMT	Notice of Status of Conditions	PRICE SENSITIVE	09/08/24	138.4KB	Share
AMT	Supplementary Bidder's Statement	PRICE SENSITIVE	08/08/24	294.93KB	Share
AMT	Declaring off-market bid free from conditions	PRICE SENSITIVE	08/08/24	132.48KB	Share
AMT	Takeover - extension of offer period	PRICE SENSITIVE	24/07/24	150.63KB	Share
AMT	First Supplementary Target's Statement	PRICE SENSITIVE	19/07/24	3.31MB	Share
AMT	Long Term Suspended Entities	PRICE SENSITIVE	10/07/24	202.22KB	Share
AMT	Extension of Offer Period	PRICE SENSITIVE	10/07/24	141.98KB	Share
AMT	Lodgement of Target's Statement	PRICE SENSITIVE	04/07/24	1.63MB	Share
AMT	Supplementary Bidder's Statement	PRICE SENSITIVE	01/07/24	162.98KB	Share
AMT	Supplementary Bidder's Statement	PRICE SENSITIVE	21/06/24	200.43KB	Share
AMT	Bidder's Statement	PRICE SENSITIVE	19/06/24	1.2MB	Share
AMT	Recommended cash takeover offer by Allegra Innovations PL	PRICE SENSITIVE	27/05/24	9.04MB	Share
AMT	Continuation of Suspension from Quotation	PRICE SENSITIVE	22/03/24	88.82KB	Share
AMT	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	22/03/24	419.65KB	Share
AMT	Suspension and Half Year Financials Update	PRICE SENSITIVE	08/03/24	135.22KB	Share
AMT	Suspension from Official Quotation	PRICE SENSITIVE	23/02/24	209.11KB	Share
AMT	Trading Halt	PRICE SENSITIVE	21/02/24	201.15KB	Share
AMT	Spinal Cage FDA Submission Update	PRICE SENSITIVE	06/02/24	149.03KB	Share
AMT	Additional Information- Spinal Cage FDA Submission Update	PRICE SENSITIVE	04/09/23	139.58KB	Share
AMT	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/23	651.8KB	Share
AMT	Results of Pro-Rata Non-Renounceable Entitlement Offer	PRICE SENSITIVE	30/08/23	197.28KB	Share
AMT	Completion of Sale of the Orthopaedic Division	PRICE SENSITIVE	28/08/23	159.77KB	Share
AMT	Spinal Cage FDA Submission Update	PRICE SENSITIVE	16/08/23	135.57KB	Share
AMT	Pro Rata Non-Renounceable Entitlement Offer Booklet	PRICE SENSITIVE	19/07/23	484.35KB	Share
AMT	Rights Issue & Update on Sale of Orthopaedic Asset	PRICE SENSITIVE	19/07/23	150.52KB	Share
AMT	Company Update on Sale of Orthopaedic Asset	PRICE SENSITIVE	02/05/23	178.06KB	Share
AMT	AMT Submits 510(k) for Spinal Cage FDA Clearance	PRICE SENSITIVE	31/03/23	191.39KB	Share
AMT	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/02/23	393.76KB	Share
AMT	Large Animal Study Completed Showing Positive Results	PRICE SENSITIVE	22/02/23	191.14KB	Share
AMT	Company Update Correction	PRICE SENSITIVE	02/02/23	185.71KB	Share
AMT	Company Update	PRICE SENSITIVE	02/02/23	184.6KB	Share
AMT	Appendix 4E and Audited Financial Statements	PRICE SENSITIVE	26/08/22	700.56KB	Share
AMT	Company Update	PRICE SENSITIVE	11/08/22	163.16KB	Share
AMT	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/02/22	930.08KB	Share
AMT	COVID 19 and FY2022 Results Guidance	PRICE SENSITIVE	19/01/22	153.18KB	Share
AMT	Appendix 4E & Full Year Statutory Accounts	PRICE SENSITIVE	26/08/21	694.55KB	Share
AMT	Loan to Progress Bone Substitute Project	PRICE SENSITIVE	28/04/21	248.73KB	Share
AMT	Successful pilot animal study	PRICE SENSITIVE	06/04/21	395.65KB	Share
AMT	Half Yearly Report	PRICE SENSITIVE	24/02/21	340.93KB	Share
AMT	Further Positive Test Results - Spinal Cage Device	PRICE SENSITIVE	21/12/20	189.67KB	Share
AMT	Spinal Cage Device Positive Test Results	PRICE SENSITIVE	04/12/20	256.56KB	Share
AMT	Appendix 4E & Full Year Statutory Accounts	PRICE SENSITIVE	27/08/20	691.11KB	Share
AMT	Sr-HT-Gahnite Spinal Cage Device Project Update	PRICE SENSITIVE	07/08/20	191.74KB	Share
AMT	Acquisition of patents for unique Synthetic Bone Substitute	PRICE SENSITIVE	06/07/20	403.51KB	Share
AMT	Update on FY2020 Orthopaedic Product Revenues	PRICE SENSITIVE	01/06/20	202.42KB	Share
AMT	Allegra to Supply Australian-made, TGA-approved Face Shields	PRICE SENSITIVE	15/04/20	136.69KB	Share
AMT	COVID-19 Update	PRICE SENSITIVE	26/03/20	242.92KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/20	324.56KB	Share
AMT	Significant Milestone for Sr-HT-Gahnite Spinal Cage Device	PRICE SENSITIVE	15/11/19	194.77KB	Share
AMT	Appendix 4E & Full Year Statutory Accounts	PRICE SENSITIVE	30/08/19	709.91KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/19	508.15KB	Share
AMT	Allegra Targets USA Market	PRICE SENSITIVE	21/11/18	344.01KB	Share
AMT	Appendix 4E & Full Year Statutory Accounts	PRICE SENSITIVE	23/08/18	1.24MB	Share
AMT	Sr-HT-Gahnite to be used with kangaroo derived tendons	PRICE SENSITIVE	03/08/18	84.59KB	Share
AMT	Allegra awarded MTPConnect BioMedTech Horizons Grant	PRICE SENSITIVE	18/04/18	621.16KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/18	489.72KB	Share
AMT	Allegra to distribute the LINK product range	PRICE SENSITIVE	14/12/17	66.13KB	Share
AMT	Private Placement	PRICE SENSITIVE	09/11/17	62.1KB	Share
AMT	Allegra Orthopaedics Limited Business Update	PRICE SENSITIVE	25/10/17	2.98MB	Share
AMT	Private Placement	PRICE SENSITIVE	08/09/17	50.55KB	Share
AMT	Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/17	723.32KB	Share
AMT	Sr-HT-Gahnite Bone Substitute Project Update	PRICE SENSITIVE	25/08/17	523.92KB	Share
AMT	Allegra signs collaboration agreement	PRICE SENSITIVE	17/08/17	120.17KB	Share
AMT	Rights Issue Offer Document	PRICE SENSITIVE	09/03/17	577.01KB	Share
AMT	Non-Renounceable Rights Issue	PRICE SENSITIVE	23/02/17	119.77KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/17	501.03KB	Share
AMT	Sr-HT-Gahnite Bone Substitute Project update	PRICE SENSITIVE	10/02/17	415.21KB	Share
AMT	Business Update-AMT.AX	PRICE SENSITIVE	31/10/16	405.23KB	Share
AMT	Conditional Placement-AMT.AX	PRICE SENSITIVE	17/10/16	181.4KB	Share
AMT	Update on Bone Substitute Project-AMT.AX	PRICE SENSITIVE	20/09/16	297.6KB	Share
AMT	Appendix 4E and Annual Report-AMT.AX	PRICE SENSITIVE	30/08/16	445.26KB	Share
AMT	Loan to Progress Bone Substitute Project-AMT.AX	PRICE SENSITIVE	30/06/16	81.24KB	Share
AMT	Promising Results for Sr-HT-Gahnite Bone Substitute-AMT.AX	PRICE SENSITIVE	07/06/16	401.02KB	Share
AMT	Management Changes-AMT.AX	PRICE SENSITIVE	20/04/16	56.8KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/16	256.08KB	Share
AMT	Update on Outsourcing of Manufacturing	PRICE SENSITIVE	04/02/16	118.05KB	Share
AMT	Management Changes	PRICE SENSITIVE	29/10/15	46.28KB	Share
AMT	Management Changes	PRICE SENSITIVE	29/09/15	121.32KB	Share
AMT	Appendix 4E and Annual Report	PRICE SENSITIVE	27/08/15	919.01KB	Share
AMT	Appendix 4D and Half-year Report	PRICE SENSITIVE	25/02/15	831.43KB	Share
AMT	Awarded $1.6M under the NSW Medical Devices Fund	PRICE SENSITIVE	31/10/14	366.63KB	Share
AMT	Trading Halt	PRICE SENSITIVE	30/10/14	20.42KB	Share
AMT	Replacement Prospectus-Rights Issue	PRICE SENSITIVE	02/10/14	6.35MB	Share
AMT	Rights Issue Prospectus	PRICE SENSITIVE	26/09/14	5.44MB	Share
AMT	NON-RENOUNCEABLE PRO RATA RIGHTS ISSUE	PRICE SENSITIVE	26/09/14	185.83KB	Share
AMT	Small Bone Innovations	PRICE SENSITIVE	22/09/14	177.79KB	Share
AMT	Preliminary Final Report	PRICE SENSITIVE	29/08/14	103.7KB	Share
AMT	Synthetic Bone Substitute Licence from University of Sydney	PRICE SENSITIVE	02/04/14	179.41KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/14	820.43KB	Share
AMT	Preliminary Final Report/Annual Report	PRICE SENSITIVE	30/08/13	948.19KB	Share
AMT	Transitional Services Agreement with Orthofix	PRICE SENSITIVE	08/08/13	175.51KB	Share
AMT	Appoints New CEO	PRICE SENSITIVE	01/05/13	164.15KB	Share
AMT	Rights Issue-Offer Document- Revised Timetable	PRICE SENSITIVE	25/02/13	404.96KB	Share
AMT	Non-Renounceable Pro Rata Rights Issue to raise $1.5m	PRICE SENSITIVE	22/02/13	135.93KB	Share

AMT Long Term Suspended Entities
18/10/24	PRICE SENSITIVE	195.7KB	Share
AMT Supplementary Bidder's Statement
09/10/24	PRICE SENSITIVE	116.43KB	Share
AMT Variation of Takeover Bid
30/09/24	PRICE SENSITIVE	155.55KB	Share
AMT Variation of Takeover Bid
16/09/24	PRICE SENSITIVE	164.03KB	Share
AMT Variation of Takeover Bid
02/09/24	PRICE SENSITIVE	149.37KB	Share
AMT Variation of Takeover Bid
16/08/24	PRICE SENSITIVE	148.6KB	Share
AMT Notice of Status of Conditions
09/08/24	PRICE SENSITIVE	138.4KB	Share
AMT Supplementary Bidder's Statement
08/08/24	PRICE SENSITIVE	294.93KB	Share
AMT Declaring off-market bid free from conditions
08/08/24	PRICE SENSITIVE	132.48KB	Share
AMT Takeover - extension of offer period
24/07/24	PRICE SENSITIVE	150.63KB	Share
AMT First Supplementary Target's Statement
19/07/24	PRICE SENSITIVE	3.31MB	Share
AMT Long Term Suspended Entities
10/07/24	PRICE SENSITIVE	202.22KB	Share
AMT Extension of Offer Period
10/07/24	PRICE SENSITIVE	141.98KB	Share
AMT Lodgement of Target's Statement
04/07/24	PRICE SENSITIVE	1.63MB	Share
AMT Supplementary Bidder's Statement
01/07/24	PRICE SENSITIVE	162.98KB	Share
AMT Supplementary Bidder's Statement
21/06/24	PRICE SENSITIVE	200.43KB	Share
AMT Bidder's Statement
19/06/24	PRICE SENSITIVE	1.2MB	Share
AMT Recommended cash takeover offer by Allegra Innovations PL
27/05/24	PRICE SENSITIVE	9.04MB	Share
AMT Continuation of Suspension from Quotation
22/03/24	PRICE SENSITIVE	88.82KB	Share
AMT Appendix 4D and Half Year Financial Report
22/03/24	PRICE SENSITIVE	419.65KB	Share
AMT Suspension and Half Year Financials Update
08/03/24	PRICE SENSITIVE	135.22KB	Share
AMT Suspension from Official Quotation
23/02/24	PRICE SENSITIVE	209.11KB	Share
AMT Trading Halt
21/02/24	PRICE SENSITIVE	201.15KB	Share
AMT Spinal Cage FDA Submission Update
06/02/24	PRICE SENSITIVE	149.03KB	Share
AMT Additional Information- Spinal Cage FDA Submission Update
04/09/23	PRICE SENSITIVE	139.58KB	Share
AMT Appendix 4E and Annual Report
31/08/23	PRICE SENSITIVE	651.8KB	Share
AMT Results of Pro-Rata Non-Renounceable Entitlement Offer
30/08/23	PRICE SENSITIVE	197.28KB	Share
AMT Completion of Sale of the Orthopaedic Division
28/08/23	PRICE SENSITIVE	159.77KB	Share
AMT Spinal Cage FDA Submission Update
16/08/23	PRICE SENSITIVE	135.57KB	Share
AMT Pro Rata Non-Renounceable Entitlement Offer Booklet
19/07/23	PRICE SENSITIVE	484.35KB	Share
AMT Rights Issue & Update on Sale of Orthopaedic Asset
19/07/23	PRICE SENSITIVE	150.52KB	Share
AMT Company Update on Sale of Orthopaedic Asset
02/05/23	PRICE SENSITIVE	178.06KB	Share
AMT AMT Submits 510(k) for Spinal Cage FDA Clearance
31/03/23	PRICE SENSITIVE	191.39KB	Share
AMT Appendix 4D and Half Year Financial Report
24/02/23	PRICE SENSITIVE	393.76KB	Share
AMT Large Animal Study Completed Showing Positive Results
22/02/23	PRICE SENSITIVE	191.14KB	Share
AMT Company Update Correction
02/02/23	PRICE SENSITIVE	185.71KB	Share
AMT Company Update
02/02/23	PRICE SENSITIVE	184.6KB	Share
AMT Appendix 4E and Audited Financial Statements
26/08/22	PRICE SENSITIVE	700.56KB	Share
AMT Company Update
11/08/22	PRICE SENSITIVE	163.16KB	Share
AMT Appendix 4D and Half Year Financial Report
24/02/22	PRICE SENSITIVE	930.08KB	Share
AMT COVID 19 and FY2022 Results Guidance
19/01/22	PRICE SENSITIVE	153.18KB	Share
AMT Appendix 4E & Full Year Statutory Accounts
26/08/21	PRICE SENSITIVE	694.55KB	Share
AMT Loan to Progress Bone Substitute Project
28/04/21	PRICE SENSITIVE	248.73KB	Share
AMT Successful pilot animal study
06/04/21	PRICE SENSITIVE	395.65KB	Share
AMT Half Yearly Report
24/02/21	PRICE SENSITIVE	340.93KB	Share
AMT Further Positive Test Results - Spinal Cage Device
21/12/20	PRICE SENSITIVE	189.67KB	Share
AMT Spinal Cage Device Positive Test Results
04/12/20	PRICE SENSITIVE	256.56KB	Share
AMT Appendix 4E & Full Year Statutory Accounts
27/08/20	PRICE SENSITIVE	691.11KB	Share
AMT Sr-HT-Gahnite Spinal Cage Device Project Update
07/08/20	PRICE SENSITIVE	191.74KB	Share
AMT Acquisition of patents for unique Synthetic Bone Substitute
06/07/20	PRICE SENSITIVE	403.51KB	Share
AMT Update on FY2020 Orthopaedic Product Revenues
01/06/20	PRICE SENSITIVE	202.42KB	Share
AMT Allegra to Supply Australian-made, TGA-approved Face Shields
15/04/20	PRICE SENSITIVE	136.69KB	Share
AMT COVID-19 Update
26/03/20	PRICE SENSITIVE	242.92KB	Share
AMT Half Yearly Report and Accounts
20/02/20	PRICE SENSITIVE	324.56KB	Share
AMT Significant Milestone for Sr-HT-Gahnite Spinal Cage Device
15/11/19	PRICE SENSITIVE	194.77KB	Share
AMT Appendix 4E & Full Year Statutory Accounts
30/08/19	PRICE SENSITIVE	709.91KB	Share
AMT Half Yearly Report and Accounts
21/02/19	PRICE SENSITIVE	508.15KB	Share
AMT Allegra Targets USA Market
21/11/18	PRICE SENSITIVE	344.01KB	Share
AMT Appendix 4E & Full Year Statutory Accounts
23/08/18	PRICE SENSITIVE	1.24MB	Share
AMT Sr-HT-Gahnite to be used with kangaroo derived tendons
03/08/18	PRICE SENSITIVE	84.59KB	Share
AMT Allegra awarded MTPConnect BioMedTech Horizons Grant
18/04/18	PRICE SENSITIVE	621.16KB	Share
AMT Half Yearly Report and Accounts
22/02/18	PRICE SENSITIVE	489.72KB	Share
AMT Allegra to distribute the LINK product range
14/12/17	PRICE SENSITIVE	66.13KB	Share
AMT Private Placement
09/11/17	PRICE SENSITIVE	62.1KB	Share
AMT Allegra Orthopaedics Limited Business Update
25/10/17	PRICE SENSITIVE	2.98MB	Share
AMT Private Placement
08/09/17	PRICE SENSITIVE	50.55KB	Share
AMT Appendix 4E and Annual Report
29/08/17	PRICE SENSITIVE	723.32KB	Share
AMT Sr-HT-Gahnite Bone Substitute Project Update
25/08/17	PRICE SENSITIVE	523.92KB	Share
AMT Allegra signs collaboration agreement
17/08/17	PRICE SENSITIVE	120.17KB	Share
AMT Rights Issue Offer Document
09/03/17	PRICE SENSITIVE	577.01KB	Share
AMT Non-Renounceable Rights Issue
23/02/17	PRICE SENSITIVE	119.77KB	Share
AMT Half Yearly Report and Accounts
23/02/17	PRICE SENSITIVE	501.03KB	Share
AMT Sr-HT-Gahnite Bone Substitute Project update
10/02/17	PRICE SENSITIVE	415.21KB	Share
AMT Business Update-AMT.AX
31/10/16	PRICE SENSITIVE	405.23KB	Share
AMT Conditional Placement-AMT.AX
17/10/16	PRICE SENSITIVE	181.4KB	Share
AMT Update on Bone Substitute Project-AMT.AX
20/09/16	PRICE SENSITIVE	297.6KB	Share
AMT Appendix 4E and Annual Report-AMT.AX
30/08/16	PRICE SENSITIVE	445.26KB	Share
AMT Loan to Progress Bone Substitute Project-AMT.AX
30/06/16	PRICE SENSITIVE	81.24KB	Share
AMT Promising Results for Sr-HT-Gahnite Bone Substitute-AMT.AX
07/06/16	PRICE SENSITIVE	401.02KB	Share
AMT Management Changes-AMT.AX
20/04/16	PRICE SENSITIVE	56.8KB	Share
AMT Half Yearly Report and Accounts
24/02/16	PRICE SENSITIVE	256.08KB	Share
AMT Update on Outsourcing of Manufacturing
04/02/16	PRICE SENSITIVE	118.05KB	Share
AMT Management Changes
29/10/15	PRICE SENSITIVE	46.28KB	Share
AMT Management Changes
29/09/15	PRICE SENSITIVE	121.32KB	Share
AMT Appendix 4E and Annual Report
27/08/15	PRICE SENSITIVE	919.01KB	Share
AMT Appendix 4D and Half-year Report
25/02/15	PRICE SENSITIVE	831.43KB	Share
AMT Awarded $1.6M under the NSW Medical Devices Fund
31/10/14	PRICE SENSITIVE	366.63KB	Share
AMT Trading Halt
30/10/14	PRICE SENSITIVE	20.42KB	Share
AMT Replacement Prospectus-Rights Issue
02/10/14	PRICE SENSITIVE	6.35MB	Share
AMT Rights Issue Prospectus
26/09/14	PRICE SENSITIVE	5.44MB	Share
AMT NON-RENOUNCEABLE PRO RATA RIGHTS ISSUE
26/09/14	PRICE SENSITIVE	185.83KB	Share
AMT Small Bone Innovations
22/09/14	PRICE SENSITIVE	177.79KB	Share
AMT Preliminary Final Report
29/08/14	PRICE SENSITIVE	103.7KB	Share
AMT Synthetic Bone Substitute Licence from University of Sydney
02/04/14	PRICE SENSITIVE	179.41KB	Share
AMT Half Yearly Report and Accounts
27/02/14	PRICE SENSITIVE	820.43KB	Share
AMT Preliminary Final Report/Annual Report
30/08/13	PRICE SENSITIVE	948.19KB	Share
AMT Transitional Services Agreement with Orthofix
08/08/13	PRICE SENSITIVE	175.51KB	Share
AMT Appoints New CEO
01/05/13	PRICE SENSITIVE	164.15KB	Share
AMT Rights Issue-Offer Document- Revised Timetable
25/02/13	PRICE SENSITIVE	404.96KB	Share
AMT Non-Renounceable Pro Rata Rights Issue to raise $1.5m
22/02/13	PRICE SENSITIVE	135.93KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

ALLEGRA MEDICAL TECHNOLOGIES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available